Literature DB >> 29939180

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors.

Jared M Newton1, Aurelie Hanoteau2, Andrew G Sikora3.   

Abstract

The tumor immune microenvironment (TIME) has recently been recognized as a critical mediator of treatment response in solid tumors, especially for immunotherapies. Recent clinical advances in immunotherapy highlight the need for reproducible methods to accurately and thoroughly characterize the tumor and its associated immune infiltrate. Tumor enzymatic digestion and flow cytometric analysis allow broad characterization of numerous immune cell subsets and phenotypes; however, depth of analysis is often limited by fluorophore restrictions on panel design and the need to acquire large tumor samples to observe rare immune populations of interest. Thus, we have developed an effective and high throughput method for separating and enriching the tumor immune infiltrate from the non-immune tumor components. The described tumor digestion and centrifugal density-based separation technique allows separate characterization of tumor and tumor immune infiltrate fractions and preserves cellular viability, and thus, provides a broad characterization of the tumor immunologic state. This method was used to characterize the extensive spatial immune heterogeneity in solid tumors, which further demonstrates the need for consistent whole tumor immunologic profiling techniques. Overall, this method provides an effective and adaptable technique for the immunologic characterization of subcutaneous solid murine tumors; as such, this tool can be used to better characterize the tumoral immunologic features and in the preclinical evaluation of novel immunotherapeutic strategies.

Entities:  

Mesh:

Year:  2018        PMID: 29939180      PMCID: PMC6101619          DOI: 10.3791/57685

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  15 in total

Review 1.  Role of the Immune Component of Tumor Microenvironment in the Efficiency of Cancer Treatment: Perspectives for the Personalized Therapy.

Authors:  Marina Stakheyeva; Vladimir Riabov; Irina Mitrofanova; Nikolai Litviakov; Evgeny Choynzonov; Nadezhda Cherdyntseva; Julia Kzhyshkowska
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

2.  CyTOF supports efficient detection of immune cell subsets from small samples.

Authors:  Yi Yao; Rebecca Liu; Min Sun Shin; Mark Trentalange; Heather Allore; Ala Nassar; Insoo Kang; Jordan S Pober; Ruth R Montgomery
Journal:  J Immunol Methods       Date:  2014-11-04       Impact factor: 2.303

3.  Application of Mass Cytometry (CyTOF) for Functional and Phenotypic Analysis of Natural Killer Cells.

Authors:  Alexander W Kay; Dara M Strauss-Albee; Catherine A Blish
Journal:  Methods Mol Biol       Date:  2016

Review 4.  Revisiting the hallmarks of cancer.

Authors:  Yousef Ahmed Fouad; Carmen Aanei
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

Review 5.  Innate and adaptive immune cells in the tumor microenvironment.

Authors:  Thomas F Gajewski; Hans Schreiber; Yang-Xin Fu
Journal:  Nat Immunol       Date:  2013-10       Impact factor: 25.606

Review 6.  The tumor microenvironment and its role in promoting tumor growth.

Authors:  T L Whiteside
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

7.  Histo-cytometry: a method for highly multiplex quantitative tissue imaging analysis applied to dendritic cell subset microanatomy in lymph nodes.

Authors:  Michael Y Gerner; Wolfgang Kastenmuller; Ina Ifrim; Juraj Kabat; Ronald N Germain
Journal:  Immunity       Date:  2012-08-02       Impact factor: 31.745

8.  Multicolor flow cytometric analysis of immune cell subsets in tumor-bearing mice.

Authors:  Lauren J Bayne; Robert H Vonderheide
Journal:  Cold Spring Harb Protoc       Date:  2013-10-01

9.  Rigorous Science: a How-To Guide.

Authors:  Arturo Casadevall; Ferric C Fang
Journal:  MBio       Date:  2016-11-08       Impact factor: 7.867

Review 10.  Advances in Cancer Immunotherapy in Solid Tumors.

Authors:  Smitha Menon; Sarah Shin; Grace Dy
Journal:  Cancers (Basel)       Date:  2016-11-24       Impact factor: 6.639

View more
  4 in total

Review 1.  Anticancer activities of phytoconstituents and their liposomal targeting strategies against tumor cells and the microenvironment.

Authors:  Jing Zhang; Xiang Li; Leaf Huang
Journal:  Adv Drug Deliv Rev       Date:  2020-05-28       Impact factor: 15.470

2.  Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition.

Authors:  Jared M Newton; Aurelie Hanoteau; Hsuan-Chen Liu; Angelina Gaspero; Falguni Parikh; Robyn D Gartrell-Corrado; Thomas D Hart; Damya Laoui; Jo A Van Ginderachter; Neeraja Dharmaraj; William C Spanos; Yvonne Saenger; Simon Young; Andrew G Sikora
Journal:  J Immunother Cancer       Date:  2019-08-13       Impact factor: 13.751

3.  Glutathione peroxidase 2 is a metabolic driver of the tumor immune microenvironment and immune checkpoint inhibitor response.

Authors:  Kazi Mokim Ahmed; Ratna Veeramachaneni; Defeng Deng; Nagireddy Putluri; Vasanta Putluri; Maria F Cardenas; David A Wheeler; William K Decker; Andy I Frederick; Sawad Kazi; Andrew G Sikora; Vlad C Sandulache; Mitchell J Frederick
Journal:  J Immunother Cancer       Date:  2022-08       Impact factor: 12.469

4.  Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy.

Authors:  Aurelie Hanoteau; Jared M Newton; Rosemarie Krupar; Chen Huang; Hsuan-Chen Liu; Angelina Gaspero; Robyn D Gartrell; Yvonne M Saenger; Thomas D Hart; Saskia J Santegoets; Damya Laoui; Chad Spanos; Falguni Parikh; Padmini Jayaraman; Bing Zhang; Sjoerd H Van der Burg; Jo A Van Ginderachter; Cornelis J M Melief; Andrew G Sikora
Journal:  J Immunother Cancer       Date:  2019-01-15       Impact factor: 13.751

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.